Cell Proliferation Kit Market Analysis

Method (Colorimetry, Fluorescence)

The global cell proliferation kit market is segmented and analyzed for demand and supply by method into colorimetry, fluorescence, and others. Out of the three types, the colorimetry segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to this technique, as it is easy to retrieve the whole dataset using this method for figuring out cell viability. The calorimetric cell viability kits are used to count the number of living cells in a culture by counting the number of electron receptors that can be reduced. In colorimetric tests, the quantity of a chemical component in a solution is determined by measuring the substance's spectral absorbance at a certain wavelength using a colorimeter (spectrophotometer). For instance, for measuring the number of live cells, colorimetric techniques using tetrazolium salts, such as MTT, XTT, and CCK-8/WST-8, are particularly helpful. The amount of viable cells in the medium may be determined using the tetrazolium salt XTT. Its foundation is the degradation of XTT by mitochondrial dehydrogenase into an orange-yellow formazan molecule that is water soluble. This approach for identifying live cells is accurate since these enzymes become inactive soon after cell death. The calorimetric cell viability kits can identify up to 250,000 viable cells and just 1000 viable cells per well.

End-user (Pharma & Biotech Companies, Academic & Research Institutes)

The global cell proliferation kit market is also segmented and analyzed for demand and supply by end-user into pharma & biotech companies, academic & research institutes, and others. Amongst these three segments, the pharma & biotech companies segment is expected to garner a significant share. The growth can be attributed to the expanding number of drug discovery projects, and increasing adoption of cloud-based drug discovery platform. Drug discovery strives to continue advancing the development of novel drugs to treat and relieve numerous diseases that are now incurable, as well as common ailments. On the other hand, throughout the last two decades, there has been a surge in both R&D spending and the release of new medications, that is anticipated to boost the segment’s growth in the market.

Our in-depth analysis of the global market includes the following segments: